These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2072775

  • 21. Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implications.
    Dutta S, Reed RC, O'Dea RF.
    Ann Pharmacother; 2006 Apr; 40(4):619-25. PubMed ID: 16569797
    [Abstract] [Full Text] [Related]

  • 22. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease.
    Maree AO, Curtin RJ, Dooley M, Conroy RM, Crean P, Cox D, Fitzgerald DJ.
    J Am Coll Cardiol; 2005 Oct 04; 46(7):1258-63. PubMed ID: 16198840
    [Abstract] [Full Text] [Related]

  • 23. Effects of nocloprost clathrate on absorption of acetylsalicylic acid.
    Siegmund W, Zschiesche M, Franke G, Amon I.
    Int J Clin Pharmacol Ther; 1994 Jan 04; 32(1):51-7. PubMed ID: 8199752
    [Abstract] [Full Text] [Related]

  • 24. Combined embryotoxic action of toluene, a widely used industrial chemical, and acetylsalicylic acid (aspirin).
    Ungváry G, Tátrai E, Lõrincz M, Barcza G.
    Teratology; 1983 Apr 04; 27(2):261-9. PubMed ID: 6867949
    [Abstract] [Full Text] [Related]

  • 25. Effects of acetylsalicylic acid on human platelet function in vivo at salicylate steady state.
    Simrock R, Missalla A, Schwidtal P, Lischke V, Breddin HK.
    Thromb Haemost; 1984 Apr 30; 51(2):269-71. PubMed ID: 6740559
    [Abstract] [Full Text] [Related]

  • 26. Rapid and sensitive determination of acetylsalicylic acid and salicylic acid in plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study.
    Xu X, Koetzner L, Boulet J, Maselli H, Beyenhof J, Grover G.
    Biomed Chromatogr; 2009 Sep 30; 23(9):973-9. PubMed ID: 19358313
    [Abstract] [Full Text] [Related]

  • 27. [Ascolong: a new buccal dosage form of acetylsalicylic acid to be used and antiaggregant].
    Kokurina EV, Suslina ZA, Khromov GL, Davydo AB, Metelitsa VI, Ionova VG, Tanashian MM, Demina EG, Bochkareva EV, Belolipetskaia VG, Deev AD, Kucheriaeva NG, Zidra SI, Gorin NN, Rumiantsev DO.
    Ter Arkh; 1998 Sep 30; 70(1):32-7. PubMed ID: 9532649
    [Abstract] [Full Text] [Related]

  • 28. Effect of transdermic acetylsalicylic acid on hemostasis in healthy volunteers.
    Martínez AB, Funosas E, Maestri L, Lucena PH.
    Acta Odontol Latinoam; 2007 Sep 30; 20(1):3-8. PubMed ID: 18046964
    [Abstract] [Full Text] [Related]

  • 29. [Experimental study of the pharmacokinetics of acetylsalicylic acid upon transdermal administration].
    Polukhina OS, Basok IuB, Salomatina LA, Sevast'ianov VI.
    Eksp Klin Farmakol; 2009 Sep 30; 72(3):29-32. PubMed ID: 19642589
    [Abstract] [Full Text] [Related]

  • 30. [The effect of exercise on the pharmacokinetics of acetaminophen and acetylsalicylic acid].
    Sawrymowicz M.
    Ann Acad Med Stetin; 1997 Sep 30; 43():57-66. PubMed ID: 9471923
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study.
    Franchi F, Schneider DJ, Prats J, Fan W, Rollini F, Been L, Taatjes-Sommer HS, Bhatt DL, Deliargyris EN, Angiolillo DJ.
    J Thromb Thrombolysis; 2022 Oct 30; 54(3):373-381. PubMed ID: 36036856
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Acetylsalicylic acid in the treatment of arterial thromboembolic diseases. 1. Pharmacologic aspects].
    Husted SE, Nielsen HK, Krusell LR, Faergeman O.
    Ugeskr Laeger; 1989 Jun 19; 151(25):1597-9. PubMed ID: 2675430
    [Abstract] [Full Text] [Related]

  • 36. [Which of the various acetylsalicylic acid preparations is the most appropriate in each indication? A pharmacokinetic study].
    Artaza MA, Castel JM, Cusidó E, Vidal X, Laporte JR.
    Med Clin (Barc); 1988 Feb 20; 90(7):283-7. PubMed ID: 3361971
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Peripheral venous plasma aspirin concentrations and platelet aggregation inhibition produced by enteric-coated aspirin formulations.
    Brandon RA, Emmett JA, Eadie MJ, Curran AC, Bunce IH.
    Thromb Haemost; 1986 Apr 30; 55(2):222-7. PubMed ID: 3715789
    [Abstract] [Full Text] [Related]

  • 39. Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function.
    Ross-Lee LM, Elms MJ, Cham BE, Bochner F, Bunce IH, Eadie MJ.
    Eur J Clin Pharmacol; 1982 Apr 30; 23(6):545-51. PubMed ID: 7160424
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of platelet function by a controlled release acetylsalicylic acid formulation--single and chronic dosing studies.
    Roberts MS, McLeod LJ, Cossum PA, Vial JH.
    Eur J Clin Pharmacol; 1984 Apr 30; 27(1):67-74. PubMed ID: 6436031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.